Trials / Completed
CompletedNCT02265484
To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism
A Randomized Open Labelled Placebo Controlled Trial to Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Institute of Liver and Biliary Sciences, India · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
After successful screening of liver cirrhosis patients attending ILBS OPD for signs of parkinsonism ( tremor, rigidity or bradykinesia, any 2 of 3). Diagnosis of hepatic/cirrhosis related parkinsonism will be made. Patients will be randomized into Bromocriptine and Placebo. Patients will be followed up every month in OPD (Out Patient Department), ILBS (Institute of liver \& Biliary Sciences) for 3 months. Detailed neurological examination will be done at each visit \& UPDRS (Unified Parkinson's Disease Rating Scale ) score will be calculated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lactulose+Rifaximin +Bromocriptine |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2015-01-01
- Completion
- 2015-01-01
- First posted
- 2014-10-16
- Last updated
- 2016-11-22
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02265484. Inclusion in this directory is not an endorsement.